Chapter 42
Medical Treatment of Poisoning with Organophosphates and Carbamates
Milan Jokanović,
Milan Jokanović
Experta Consulting, Nehruova 57, 11070 Belgrade, Serbia and Academy of Sciences and Arts of Republic Srpska, Banja Luka, Republic Srpska, Bosnia and Herzegovina
Search for more papers by this authorMilan Jokanović,
Milan Jokanović
Experta Consulting, Nehruova 57, 11070 Belgrade, Serbia and Academy of Sciences and Arts of Republic Srpska, Banja Luka, Republic Srpska, Bosnia and Herzegovina
Search for more papers by this authorBook Editor(s):Tetsuo Satoh,
Ramesh C. Gupta,
Tetsuo Satoh
Department of Pharmacology and Toxicology, Japan
Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
HAB Research Institute, Ichikawa, Chiba, Japan
Search for more papers by this authorRamesh C. Gupta
Toxicology Department, Breathitt Veterinary Center, Murray State University, Hopkinsville, KY, USA
Search for more papers by this authorFirst published: 18 January 2011
Summary
This chapter contains sections titled:
-
Introduction
-
Interaction of Cholinesterases with OP and CM Compounds
-
Clinical Aspects of Acute Poisoning with OP Compounds
-
Antidotes in the Treatment of Human Poisoning with OP Pesticides
-
Medical Treatment of Patients Acutely Poisoned with OP Pesticides
-
Clinical Aspects and Medical Treatment of Poisoning with CMs
-
Possibilities of Medical Treatment of Other Toxic Effects Caused by OP Pesticides
-
Conclusions
-
Acknowledgments
-
References
References
- Aas, P. (1996). In vitro effects of toxogonin, HI-6 and HLö-7 on the release of [3H] acetylcholine from peripheral cholinergic nerves in rat airway smooth muscle. Eur. J. Pharmacol. 301: 59–66.
- Abdel-Rahman, A., Shetty, A.K., and Abou-Donia, M.B. (2002). Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose–response relationships. Neuroscience 113: 721–741.
- Alkondon, M., Rao, K.S., and Albuquerque, E.X. (1988). Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel. J. Pharmacol. Exp. Ther. 245: 543–556.
- Antonijević, B., and Stojiljković, M.P. (2007). Unequal efficacy of pyridinium oximes in acute organophosphorus poisoning. Clin. Med. Res. 5: 71–78.
- Aragao, I., Soares, M.E., Bastos, M.L., and Lopes, M. (1996). Continuous infusion of obidoxime and the importance of plasma levels monitoring in organophosphate poisoning. Intens. Care Med. 22(Suppl 3): S388, 512.
- Ashani, Y., Bhattacharjee, A.K., Leader, H., Saxena, A., and Doctor, B.P. (2003). Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem. Pharmacol. 66: 191–202.
- Balali-Mood, M., and Shariat, M. (1998). Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J. Physiol. Paris 92: 375–378.
- Baron, R.L. (1991). Carbamate insecticides. In: W.J. Hayes, E.R. Laws, (Eds) Handbook of Pesticide Toxicology. Vol. 3, Chapter 17. Academic Press, San Diego, pp. 1129.
-
Bismuth, C., Inns, R.H., and Marrs, T.C. (1992). Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: B. Ballantyne, T.C. Marrs, (Eds) Clinical and Experimental Toxicology of Organophosphates and Carbamates. Chapter 52. Butterworth-Heinemann, Oxford, pp. 555–577.
10.1016/B978-0-7506-0271-6.50058-9 Google Scholar
- Bokonjić, D., Jovanović, D., Jokanović, M., and Maksimović, M. (1987). Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats. Arch. Int. Pharmacodyn. 288: 309–318.
- Bošković, B., Vojvodić, V., Maksimović, M., Granov, A., Besarović-Lazarev, S., and Binenfeld, Z. (1976). Effect of mono- and bis-quaternary pyridinium oximes on the serum cholinesterase inhibitory activity of dioxacarb, carbaryl and carbofuran. Arh. Hig. Rada 27: 289–295.
- Burgess, J.L., Bernstein, J.N., and Hurlbut, K. (1994). Aldicarb poisoning. A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy. Arch. Int. Med. 154: 221–224.
- Carpentier, P., Delamanche, I.S., Le Bert, M., Blanchet, G., and Bouchard, C. (1990). Seizure-related opening of the blood– brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. NeuroToxicology 11: 493–508.
-
Cherian, M.A., Roshini, C., Peter, J.V., and Cherian, A.M. (2005). Oximes in organophosphorus poisoning. Indian J. Crit. Care Med. 9: 155–163.
10.4103/0972-5229.19682 Google Scholar
- Clement, J. (1979). Pharmacological actions of HS-6, an oxime, on the neuromuscular junction. Eur. J. Pharmacol. 53: 135–141.
- Clement, J.G. (1981). Toxicology and pharmacology of bispyridinium oximes—insight into the mechanism of action vs. soman poisoning in vivo. Fundam. Appl. Toxicol. 1: 193–202.
- Darvesh, S., Hopkins, D.A., and Geula, C. (2003). Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 4: 131–138.
- Dawson, R.M. (1995). Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinetsrase for pyri-dine, physostigmine and insecticidal carbamates. Neurochem. Int. 26: 643–654.
-
De Bleecker, J.L. (2006). Intermediate syndrome in organophosphate poisoning. In: R.C. Gupta (Ed.) Toxicology of Organophosphate and Carbamate Compounds. Chapter 26. Elsevier Academic Press, Amsterdam, pp. 371–380.
10.1016/B978-012088523-7/50027-2 Google Scholar
- De Bleecker, J., Van Den Neucker, K., and Colardyn, F. (1993). Intermediate syndrome in organophosphorus poisoning: a prospective study. Crit. Care Med. 21: 1706–1711.
- De Silva, H.J., Wijewickrema, R., and Senanayake, N. (1992). Does pralidoxime affect outcome of management in acute organophosphate poisoning? Lancet 339: 1136–1138.
- Eddleston, M., Juszczak, E., and Buckley, N.A. (2005a). Randomised controlled trial of routine single or multiple dose superactivated charcoal for self-poisoning in a region with high mortality. Clin. Toxicol. 43: 442–443.
- Eddleston, M., Singh, S., Buckley, N. (2006). Organophosphorus poisoning (acute). Clin. Evid. 15: 1–13.
- Eddleston, M., Juszczak, E., Buckley, N.A., Senarathna, L., Mohamed, F., Dissanayake, W., Hittarage, A., Azher, S., Jeganathan, K., Jayamanne, S., Sheriff, M.H.R., and Warrell, D.A. (2008). Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet 371: 579–587.
- Eddleston, M., Eyer, P., Worek, F., Mohamed, F., Senarathna, L., von Meyer, L., Juszczak, E., Hittarage, A., Azhar, S., Dissanayake, W., Sheriff, M.H.R., Szinicz, L., Dawson, A.H., and Buckley, N.A. (2005b). Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 366: 1452–1459.
- Eyer, P. (2003). The role of oximes in the management of organo-phosphorus pesticide poisoning. Toxicol. Rev. 22: 165–190.
- Garber, M. (1987). Carbamate poisoning: the “other” insecticide. Pediatrics 79: 734–738.
- Glynn, P. (1999). Neuropathy target esterase. Biochem. J. 344: 625–631.
- Glynn, P. (2006). A mechanism for organophosphate-induced delayed neuropathy. Toxicol. Lett. 162: 94–97.
- Grange-Messent, V., Bouchaud, C., Jamme, M., Lallement, G., Foguin, A., and Carpentier, P. (1999). Seizure-related opening of the blood–brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations. Cell. Mol. Biol. 45: 1–14.
- Hamilton, G., and Lundy, P.M. (1989). HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch. Toxicol. 63: 144–149.
-
Heath, A.J.W., and Meredith, T. (1992). Atropine in the management of anticholinesterase poisoning. In: B. Ballantyne, T.C. Marrs, (Eds) Clinical and Experimental Toxicology of Organophosphates and Carbamates. Chapter 51. ButterworthHeinemann, Oxford, pp. 543–554.
10.1016/B978-0-7506-0271-6.50057-7 Google Scholar
- IPCS (1998). Organophosphorus pesticides. International Programme on Chemical Safety Poisons Information Monograph G001, World Health Organization, Geneva, 1989; updated 1998. Available online at: http://www.inchem.org/documents/ pims/chemical/pimg001.htm
- IPCS (2002). Antidotes for Poisoning by Organophosphorus Pesticides. Monograph on Atropine. International Programme on Chemical Safety Evaluation. World Health Organization, Geneva.
- Jagger, B.V., and Stagg, G.N. (1958). Toxicity of diacetylmonoxime and of pyridine-2-aldoxime methiodide in man 15–30 mg/kg 2-PAM: no effects on EEG in a healthy man. Bull. Johns Hopkins Hosp. 102: 203–211.
- Johnson, M.K. (1982). The target for initiation of delayed neurotoxi-city by organophosphorus esters: biochemical studies and toxicological applications. In: E. Hodgson, J.R. Bend, R.M. Philpot (Eds) Revews in Biochemical Toxicology. Vol. 4. Elsevier, New York, pp. 141–212.
- Johnson, M.K., and Vale, J.A. (1992). Clinical management of acute organophosphate poisoning: an overview. In: B. Ballantyne, T.C. Marrs (Eds) Clinical and Experimental Toxicology of Organophosphates and Carbamates. Butterworth-Heinemann, Oxford, pp. 528–535.
- Johnson, S., Peter, J.V., Thomas, K., Jeyaseelan, L., and Cherian, A.M. (1996). Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning. J. Assoc. Physic. India 44: 529–531.
- Johnson, M.K., Jacobsen, D., Meredith, T.J., Eyer, P., Heath, A.J., Ligtenstein, D.A., Marrs, T.C., Szinicz, L., Vale, A.J., and Haines, J.A. (2000). Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg. Med. 12: 22–37.
- Jokanović, M. (2001). Biotransformation of organophosphorus compounds. Toxicology 166: 139–160.
-
Jokanović, M. (2009). Neuropathy: chemically-induced. In: L. Squire, T. Albright, F. Bloom, F. Gage, N. Spitzer (Eds) Encyclopedia of Neuroscience. Chapter 515. Elsevier, 759–765.
10.1016/B978-008045046-9.00515-5 Google Scholar
- Jokanović, M., and Maksimović, M. (1995). A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in treatment of oral organophosphorus insecticide poisoning. Arch. Toxicol. 70: 119–123.
- Jokanović, M., and Maksimović, M. (1997). Abnormal cholinesterase activity: understanding and interpretation. Eur. J. Clin. Chem. Clin. Biochem. 35: 11–16.
- Jokanović, M., and Stojiljković, M.P. (2006). Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur. J. Pharmacol. 553: 10–17.
- Jokanović, M., and Prostran, M. (2009). Pyridinium oximes as cholinesterase reactivators. Structure–activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr. Medic. Chem. 16/17: 2177–2188.
- Jokanović, M., Stukalov, P.V., and Kosanović, M. (2002). Organophosphate induced delayed polyneuropathy. Current Drug Targets—CNS & Neurological Disorders 1: 591–600.
-
Jokanović, M., Kosanović, M., and Stukalov, P.V. (2004). Organophosphate induced delayed polyneuropathy. Medic. Chem. Rev. Online 1: 123–131.
10.2174/1567203043480377 Google Scholar
- Jovanović, D., Maksimović, M., Joksović, D., and Kovačević, V. (1990). Oral forms of the oxime HI-6:a study of pharmacokinetics and tolerance after administration to healthy volunteers. Vet. Hum. Toxicol. 32: 419–421.
-
Karchmar, A.G. (2007). Anticholinesterases and war gases. In: A.G. Karchmar (Ed.) Exploring the Vertebrate Central Cholinergic Nervous System. Chapter 7. Springer, pp. 237–310.
10.1007/978-0-387-46526-5_7 Google Scholar
- Kassa, J. (2005). The role of oximes in the antidotal treatment of chemical casualties exposed to nerve agents. In: A. Monov, C. Dishovsky, (Eds) Medical Aspects of Chemical and Biological Terrorism. Chemical Terrorism and Traumatism. Publishing House of the Union of Scientists in Bulgaria, Sofia, pp. 193–208. Available at http://www.jmedchemdef.org/ archives.html.
- Kiderlen, D., Eyer, P., and Worek, F. (2005). Formation and disposition of diethylphosphoryl-obidoxime, a potent anticholinesterase that is hydrolysed by human paraoxonase (PON1). Biochem. Pharmacol. 69: 1853–1867.
- Kloog, Y., Galron, R., and Sokolovsky, M. (1986). Bisquarternary pyridinium oximes as presynaptic agonists and postsynaptic antagonists of muscarinic receptors. J. Neurochem. 46: 767–772.
- Kušić, R., Bošković, B., Vojvodić, V., and Jovanović, D. (1985). HI-6 in man: blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers. Fundam. Appl. Toxicol. 5: S89–S97.
- Kušić, R., Jovanović, D., Randelović, S., Joksović, D., Todorović, V., Bošković, B., Jokanović, M., and Vojvodić, V. (1991). HI-6 in man: efficacy of the oxime in poisoning by organo-phosphorus insecticides. Human Exp. Toxicol. 10: 113–118.
- Lieske, C.N., Clark, J.H., Maxwell, D.M., Zoeffel, L.D., and Sultan, W.E. (1992). Studies of the amplification of carbaryl toxicity by various oximes. Toxicol. Lett. 62: 127–137.
- Lotti, M. (1992). The pathogenesis of organophosphate delayed polyneuropathy. Crit. Rev. Toxicol. 21: 465–487.
- Lotti, M., and Moretto, A. (2005). Organophosphate-induced delayed polyneuropathy. Toxicol. Rev. 24: 37–49.
- Luo, C., Saxena, A., Smith, M., Garcia, G., Radić, Z., Taylor, P., and Doctor, B.P. (1999). Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium. Biochemistry 38: 9937–9947.
- Marrs, T.C. (2004). Diazepam. Antidotes for Poisoning by Organophosphorus Pesticides. International Programme on Chemical Safety, World Health Organization.
-
Marrs, T.C., and Vale, J.A. (2006). Management of organophosphorus pesticide poisoning. In: R.C. Gupta (Eds) Toxicology of Organophosphorus and Carbamate Compounds, Chapter 49. Elsevier Academic Press, Amsterdam, pp. 715–733.
10.1016/B978-012088523-7/50050-8 Google Scholar
- Mason, H.J., Sams, C., Stevenson, A.J., and Rawborne, R. (2000). Rates of spontaneous reactivation and aging of acetylcholinesterase in human erythrocytes after inhibition by organophosphorus pesticides. Hum. Exp. Toxicol. 19: 511–516.
- McDonough, J.H. Jr., McLeod, C.G. Jr., and Nipwoda, M.D. (1987). Direct micro-injection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 435: 123–137.
- Melchers, B.P.C., van der Laaken, A.L., Busker, R.W., Bruijnzeel, P.L.B., and van Helden, H.P.M. (1994). Non-reactivating effects of HI-6 on hippocampal neurotransmission. Arch. Toxicol. 69: 118–126.
- Milatović, D., and Jokanović, M. (2009). Pyridinium oximes as cholinesterase reactivators in the treatment of poisoning with organophosphorus compounds. In: R.C. Gupta (Ed.) Handbook of Toxicology of Chemical Warfare Agents, Chapter 65. Elsevier, pp. 985–996.
- Morgan, J.P. (1982). The Jamaica ginger paralysis. J. Am. Med. Assoc. 248: 1864–1867.
- Øydvin, O.K., Tansø, R., and Aas, P. (2005). Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication. Eur. J. Pharmacol. 516: 227–234.
- Pawar, K.S., Bhoite, R.R., Pillay, C.P., Chavan, S.C., Malshikare, D.S., and Garad, S.G. (2006). Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 368: 2136–2141.
- Pazdernik, T.L., Nelson, S.R., Cross, R., Churchill, L., Giesler, M., and Samson, F.E. (1986). Effects of antidotes on soman-induced brain damage. Arch. Toxicol. 9: 333–336.
- Peng, A., Meng, F.-Q., Sun, L.-F., Ji, Z.-S., and Li, Y.-H. (2004). Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning. Acta Pharmacol. Sin. 25: 15–21.
- Portella, R.L., Barcelos, R.P., de Bem, A.F., Carratu, V.S., Bresolin, L., Rocha, J.B.T., and Soares, F.A.A. (2008). Oximes as inhibitors of low density lipoprotein oxidation. Life Sci. 83: 878–885.
- Reiner, E., and Pleština, R. (1979). Regeneration of cholinesterase activities in humans and rats after inhibition by O,O-dimethyl-O-dimethyl-2,2-dichlorvinyl phosphate. Toxicol. Appl. Pharmacol. 49: 451–454.
- Rotenberg, M., Shefi, M., Dany, S., Dore, I., Tirosh, M., and Almog, S. (1995). Differentiation between organophosphate and carba-mate poisoning. Clinica Chimica Acta 234: 11–21.
- Sakurada, K., Matsubara, K., Shimizu, K., Shiono, H., Seto, Y., Tsuge, K., Yoshino, M., Sakai, I., Mukoyama, H., and Takatori, T. (2003). Pralidoxime iodide (2-PAM) penetrates accross the blood–brain barrier. Neurochem. Res. 28: 1401–1407.
- Schoene, K., and Wulf, K. (1972). Retarding effect of pyridinium salts on ageing of soman-inhibited acetylcholinesterase. Arzmittelforsch. 22: 1802.
- Schoene, K., Steinhanses, J., and Oldiges, H. (1976). Protective activity of pyridinium salts against soman poisoning in vivo and in vitro. Biochem. Pharmacol. 25: 1955–1958.
-
Sellström, A. (1992). Anticonvulsants in anticholinesterase poisoning. In: B. Ballantyne, T.C. Marrs (Eds) Clinical and Experimental Toxicology of Organophosphates and Carbamates, Butterworth-Heinemann, Oxford, pp. 578–586.
10.1016/B978-0-7506-0271-6.50059-0 Google Scholar
- Senanayake, N., and Karalliedde, L. (1987). Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. New Engl. J. Med. 316: 761–763.
- Shiloff, J.D., and Clement, J.G. (1987). Comparison of serum concentration of the acetylcholinesterase oxime reactivatiors HI-6, obidoxime and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats. Toxicol. Appl. Pharmacol. 89: 278–280.
- Sidell, F.R., and Groff, W.A. (1970). Toxogonin: blood levels and side effects after intramuscular administration in man. J. Pharm. Sci. 59: 793–797.
- Sidell, F.R., and Groff, W.A. (1971). Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man. J. Pharm. Sci. 60: 1224–1228.
- Simon, F.A., and Pickering, L.K. (1976). Acute yellow phosphorus poisoning:“Smoking stool syndrome”. J. Am. Med. Assoc. 235: 1343–1344.
- Singh, S., Batra, Y.K., Singh, S.M., Wig, N., and Sharma, B.K. (1995). Is atropine alone sufficient in acute severe organophosphate poisoning? Experience of a North West Indian hospital. Int. J. Clin. Pharmacol. Ther. 33: 628–630.
- Stepanović Petrović, R.M., Jokanović, M., Maksimović, M., Ugrešić, N., and Bošković, B. (2000). The treatment of delayed polyneuropathy induced with diisopropylfluorophosphate in hens. Pharmazie 55: 454–455.
- Sterri, S.H., Rognerud, B., Fiskum, S.E., and Lyngaas, S. (1979). Effect of toxogonin and P2S on the toxicity of carbamates and organophosphorus compounds. Acta Pharmac. Toxicol. 45: 9–15.
- Stojiljković, M.P., and Jokanović, M. (2005). AUM Shinrikyo and terrorist use of nerve agents in Japan. In: A. Monov, C. Dishovsky (Eds) Medical Aspects of Chemical and Biological Terrorism: Chemical Terrorism and Traumatism, Publishing House of the Union of Scientists in Bulgaria, Sofia, Bulgaria, pp. 101–115. Available at http://www.jmedchemdef. org/archives.html.
- Thiermann, H., Mast, U., Klimmek, R., Eyer, P., Hibler, A., Pfab, R., Felgenhauer, N., and Zilker, T. (1997). Cholinesterase status, pharmacokinetics, and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum. Exp. Toxicol. 16: 473–480.
- Thiermann, H., Szinicz, L., Eyer, F., Worek, F., Eyer, P., Felgenhauer, N., and Zilker, T. (1999). Modern strategies in therapy of organophosphate poisoning. Toxicol. Lett. 107: 233–239.
- van Helden, H.P.M., Van der Weil, H.J., and Wolthuis, O.L. (1983). Therapy of organophosphate poisoning; the marmoset as a model for man. Br. J. Pharmacol. 78: 579–589.
- van Helden, H.P.M., Busker, R.W., Melchers, B.P.C., and Bruijnzeel, P.L.B. (1996). Pharmacological effects of oximes: how relevant are they? Arch. Toxicol. 70: 779–786.
- van Helden, H.P.M., Groen, B., Moor, E., Westerink, B.H.C., and Bruijnzeel, P.L.B. (1998). New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem. Toxicol. 21(Suppl 1): 171–181.
- van Helden, H.P.M., Van der Weil, H.J., de Lange, J., Busker, R.W., Melchers, B.P.C., and Wolthuis, O.L. (1992). Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl. Pharmacol. 115: 50–56.
- van Tienhoven, M., Atkins, J., Li, Y., and Glynn, P. (2002). Human neuropathy target esterase catalyses hydrolysis of membrane lipids. J. Biol. Chem. 277: 20942–20948.
- Willems, J.L., De Bisschop, H.C., Verstraete, A.G., Declerck, C., Christiaens, Y., Vanscheeuwyck, P., Buylaert, W.A., Vogelaers, D., and Colardyn, F. (1993). Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate. Arch. Toxicol. 67: 79–84.
- Worek, F., Diepold, C., and Eyer, P. (1999). Dimethylphosphoryl-inhibited human cholinesterases: Inhibition, reactivation, and aging kinetics. Arch. Toxicol. 73: 7–14.
- Worek, F., Eyer, P., Kiderlen, D., Thiermann, H., and Szinicz, L. (2000). Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase. Arch. Toxicol. 74: 21–26.
- Worek, F., Eyer, P., Aurbek, N., Szinicz, L., and Thiermann, H. (2007). Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Toxicol. Appl. Pharmacol. 219: 226–234.
- World Health Organization (1986). Organophosphorus insecticides: a general introduction. Environmental Health Criteria, Vol. 63. WHO, Geneva.
- Yang, C.-C., and Deng, J.-F. (2007). Intermediate syndrome following organophosphate insecticide poisoning. J. Chin. Med. Assoc. 70: 467–472.
- Zilker, T. (2005). Medical management of incidents with chemical warfare agents. Toxicology 214: 221–231.
